Fact Sheet: A Science-Led Partner for Alzheimer’s Disease Clinical Development
Alzheimer’s Disease CRO Expertise for Complex Clinical Trials
As Alzheimer’s research shifts toward earlier intervention and biomarker-defined populations, sponsors need more than operational support. They need a partner who understands the scientific and operational complexities that drive successful development programs.
P95 Julius Clinical integrates academic scientific expertise, global clinical operations, and real-world evidence capabilities to support Alzheimer’s disease programs from study design through late-stage development and beyond.
Download our Alzheimer’s Disease Fact Sheet to learn how we help sponsors overcome recruitment challenges, manage complex endpoints, and generate high-quality evidence across the product lifecycle.
Complete the form to access the fact sheet.
Related resources
Peer Reviewed Publication: Evaluating Gender Representation in Alzheimer’s Disease Trial Eligibility Criteria
Ensuring that Alzheimer’s disease (AD) clinical trials reflect real-world patient populations remains a key challenge, as eligibility criteria can unintentionally influence who is able to participate. A recent study published in The Journal of P...